• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity.

作者信息

Sagris Dimitrios, Lip Gregory Y H

机构信息

Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom.

Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Thessaly, Greece.

出版信息

Lancet Reg Health Eur. 2022 May 4;17:100395. doi: 10.1016/j.lanepe.2022.100395. eCollection 2022 Jun.

DOI:10.1016/j.lanepe.2022.100395
PMID:35721698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9198840/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/9198840/75a62ec47855/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/9198840/75a62ec47855/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e589/9198840/75a62ec47855/gr1.jpg

相似文献

1
Atrial fibrillation, a contemporary sign of multimorbidity and irregular social inequity.心房颤动，一种多重疾病和社会不平等现象的现代标志。
Lancet Reg Health Eur. 2022 May 4;17:100395. doi: 10.1016/j.lanepe.2022.100395. eCollection 2022 Jun.
2
Management of Atrial Fibrillation in Older Patients by Morbidity Burden: Insights From Get With The Guidelines-Atrial Fibrillation.基于发病率负担的老年心房颤动患者管理：来自 Get With The Guidelines-Atrial Fibrillation 的见解。
J Am Heart Assoc. 2020 Dec;9(23):e017024. doi: 10.1161/JAHA.120.017024. Epub 2020 Nov 26.
3
Effects of the Atrial Fibrillation Better Care Pathway on Outcomes Among Clinically Complex Chinese Patients With Atrial Fibrillation With Multimorbidity and Polypharmacy: A Report From the ChiOTEAF Registry.《房颤优化管理路径对伴有多种合并症和多种药物治疗的临床复杂中国房颤患者结局的影响：来自 ChiOTEAF 登记研究的报告》。
J Am Heart Assoc. 2022 Apr 5;11(7):e024319. doi: 10.1161/JAHA.121.024319. Epub 2022 Apr 4.
4
Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.75 岁及以上心房颤动患者共病与心血管终点事件及治疗效果的关系。
Am J Med. 2020 Oct;133(10):e554-e567. doi: 10.1016/j.amjmed.2020.03.038. Epub 2020 Apr 19.
5
Relationship between multimorbidity and outcomes in atrial fibrillation.多种共存疾病与心房颤动结局的关系。
Exp Gerontol. 2021 Oct 1;153:111482. doi: 10.1016/j.exger.2021.111482. Epub 2021 Jul 23.
6
Generating Items for Measuring Needs-Based Quality of Life and Self-Perceived Health Inequity in Patients with Multimorbidity: Development of the MultiMorbidity Questionnaire (MMQ).生成用于测量多病共存患者基于需求的生活质量和自我感知健康不平等的条目：多病共存问卷（MMQ）的开发。
Patient Relat Outcome Meas. 2023 Oct 10;14:269-282. doi: 10.2147/PROM.S427183. eCollection 2023.
7
The Effects of Implementing a Mobile Health-Technology Supported Pathway on Atrial Fibrillation-Related Adverse Events Among Patients With Multimorbidity: The mAFA-II Randomized Clinical Trial.移动医疗技术支持路径对合并多种疾病患者心房颤动相关不良事件的影响：mAFA-II 随机临床试验。
JAMA Netw Open. 2021 Dec 1;4(12):e2140071. doi: 10.1001/jamanetworkopen.2021.40071.
8
Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity.非瓣膜性心房颤动合并多种疾病患者中直接口服抗凝剂的有效性和安全性。
Adv Ther. 2023 Mar;40(3):887-902. doi: 10.1007/s12325-022-02387-9. Epub 2022 Dec 17.
9
Multimorbidity in patients with atrial fibrillation.心房颤动患者的多种合并症。
Open Heart. 2024 Mar 19;11(1):e002641. doi: 10.1136/openhrt-2024-002641.
10
Multimorbidity, polypharmacy and inappropriate prescribing in elderly patients with atrial fibrillation: A report from the China Atrial Fibrillation Registry Study.老年房颤患者的多重疾病、多种药物治疗及不适当处方：来自中国房颤注册研究的报告
Front Cardiovasc Med. 2022 Sep 6;9:988799. doi: 10.3389/fcvm.2022.988799. eCollection 2022.

引用本文的文献

1
[MVP Risk score and new atrial fibrillation diagnosis: Prospective cohort PREFATE study].[MVP风险评分与新发房颤诊断：前瞻性队列PREFATE研究]
Aten Primaria. 2025 Jan;57(1):103071. doi: 10.1016/j.aprim.2024.103071. Epub 2024 Sep 11.
2
Pharmacy-Led Management of Atrial Fibrillation: Improving Treatment Adherence and Patient Outcomes.由药房主导的心房颤动管理：提高治疗依从性及改善患者预后
Integr Pharm Res Pract. 2024 Jul 29;13:101-114. doi: 10.2147/IPRP.S397844. eCollection 2024.
3
Protocol for a multicentre and prospective follow-up cohort study of early detection of atrial fibrillation, silent stroke and cognitive impairment in high-risk primary care patients: the PREFA-TE study.

本文引用的文献

1
Temporal trends and patterns in atrial fibrillation incidence: A population-based study of 3·4 million individuals.心房颤动发病率的时间趋势和模式：一项基于340万个体的人群研究。
Lancet Reg Health Eur. 2022 Apr 25;17:100386. doi: 10.1016/j.lanepe.2022.100386. eCollection 2022 Jun.
2
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide.如何使用数字设备检测和管理心律失常：欧洲心律协会实用指南
Europace. 2022 Jul 15;24(6):979-1005. doi: 10.1093/europace/euac038.
3
2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary.
高危初级保健患者心房颤动、无症状性卒中和认知障碍早期检测的多中心前瞻性随访队列研究方案：PREFA-TE研究
BMJ Open. 2024 Feb 19;14(2):e080736. doi: 10.1136/bmjopen-2023-080736.
4
Trends in Atrial Fibrillation Management-Results from a National Multi-Center Urgent Care Network Registry.心房颤动管理趋势——来自全国多中心紧急护理网络登记处的结果
J Clin Med. 2023 Oct 24;12(21):6704. doi: 10.3390/jcm12216704.
5
Stroke in Atrial Fibrillation and Other Atrial Dysrhythmias.心房颤动及其他房性心律失常中的卒中
Curr Cardiol Rep. 2023 May;25(5):357-369. doi: 10.1007/s11886-023-01862-1. Epub 2023 Mar 28.
2021 年亚太心律学会心房颤动卒中预防聚焦更新共识指南：执行摘要。
Thromb Haemost. 2022 Jan;122(1):20-47. doi: 10.1055/s-0041-1739411. Epub 2021 Nov 13.
4
Revisiting the dynamic risk profile of cardiovascular/non-cardiovascular multimorbidity in incident atrial fibrillation patients and five cardiovascular/non-cardiovascular outcomes: A machine-learning approach.重新审视初发性房颤患者心血管/非心血管共病的动态风险特征及五种心血管/非心血管结局：一种机器学习方法。
J Arrhythm. 2021 Jun 22;37(4):931-941. doi: 10.1002/joa3.12555. eCollection 2021 Aug.
5
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation: Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients.房颤患者遵循“房颤优化管理路径”：对 28.5 万名患者临床结局的影响——系统评价和荟萃分析。
Thromb Haemost. 2022 Mar;122(3):406-414. doi: 10.1055/a-1515-9630. Epub 2021 Jun 21.
6
Improving Stroke Risk Prediction in the General Population: A Comparative Assessment of Common Clinical Rules, a New Multimorbid Index, and Machine-Learning-Based Algorithms.提高普通人群中风风险预测能力：常见临床规则、新的多病指数和基于机器学习算法的比较评估。
Thromb Haemost. 2022 Jan;122(1):142-150. doi: 10.1055/a-1467-2993. Epub 2021 May 28.
7
Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.全球心血管疾病负担及危险因素, 1990-2019:来自 GBD 2019 研究的更新。
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010.
8
Socioeconomic position and risk of atrial fibrillation: a nationwide Danish cohort study.社会经济地位与心房颤动风险：一项全国性丹麦队列研究。
J Epidemiol Community Health. 2020 Jan;74(1):7-13. doi: 10.1136/jech-2019-212720. Epub 2019 Oct 16.
9
The ABC pathway: an integrated approach to improve AF management.ABC路径：改善房颤管理的综合方法。
Nat Rev Cardiol. 2017 Nov;14(11):627-628. doi: 10.1038/nrcardio.2017.153. Epub 2017 Sep 29.
10
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.欧盟心房颤动患者数量预测，从 2000 年至 2060 年。
Eur Heart J. 2013 Sep;34(35):2746-51. doi: 10.1093/eurheartj/eht280. Epub 2013 Jul 30.